ClinicalTrials.govpublic full text
Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies
dyslipidemias, hypercholesterolemia, familial hypercholesterolemia, ascvd, high cholesterol
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 154843
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.